scieee Science in your language
[en] (orig)

Serum metallothioneins in childhood tumours – A potential prognostic marker

Abstract

Metallothioneins (MT) are low molecular weight, cysteine-rich proteins maintaining metal ions homeostasis. They play a role in carcinogenesis and may also cause chemoresistance. The aim of the study was to explore the importance of MT serum levels in children suffering from malignant tumours. This prospective study involves examination of 865 samples from 172 patients with malignant tumours treated from 2008 to 2011 at University Hospital Motol. MT serum levels were determined using differential pulse voltammetry–Brdicka reaction

Read accessible full text

Serum metallothioneins in childhood tumours – A potential prognostic marker

Author: Kruseová, Jarmila; Hynek, David; Adam, Vojtěch; Kizek, René; Průša, Richard; Hraběta, Jan; Eckschlager, Tomáš
Publisher: MDPI
Year: 2013
DOI: 10.3390/ijms140612170
Source: https://dspace.vut.cz/bitstreams/e73b43de-8276-440f-89e9-55789eeb8764/download
In . J. Mol. Sci. 2013, 14, 12170-12185; doi:10.3390/ijms140612170
In e na ional Jou nal o
Molecula Sciences
ISSN 1422-0067
www.mdpi.com/jou nal/ijms
A icle
Se um Me allo hioneins in Childhood Tumou s—A Po en ial
P ognos ic Ma ke
Ja mila K useo a 1, Da id Hynek 2,3, Voj ech Adam 2,3, Rene Kizek 2,3, Richa d P usa 4,
Jan H abe a 1 and Tomas Eckschlage 1,*
1 Depa men o Paedia ic Haema ology and Oncology, 2nd Medical Facul y and
Uni e si y Hospi al Mo ol, V U alu 84, P ague CZ 150 06, Czech Republic;
E-Mails: ja mila.k useo a@ nmo ol.cz (J.K.); [email p o ec ed] (J.H.)
2 Depa men o Chemis y and Biochemis y, Facul y o Ag onomy, Mendel Uni e si y in B no,
Zemedelska 1, B no CZ 613 00, Czech Republic; E-Mails: [email p o ec ed] (D.H.);
[email p o ec ed] (V.A.); [email p o ec ed] (R.K.)
3 Cen al Eu opean Ins i u e o Technology, B no Uni e si y o Technology, Technicka 3058/10,
B no CZ 616 00, Czech Republic
4 Depa men o Medical Chemis y and Clinical Biochemis y, 2nd Medical Facul y and
Uni e si y Hospi al Mo ol, V U alu 84, P ague CZ 150 06, Czech Republic;
E-Mail: [email p o ec ed]
* Au ho o whom co espondence should be add essed; E-Mail: [email p o ec ed];
Tel.: +42-0-224-436-450; Fax: +42-0-224-436-420.
Recei ed: 10 Ap il 2013; in e ised o m: 22 May 2013 / Accep ed: 30 May 2013 /
Published: 6 June 2013
Abs ac : Me allo hioneins (MT) a e low molecula weigh , cys eine- ich p o eins
main aining me al ions homeos asis. They play a ole in ca cinogenesis and may also cause
chemo esis ance. The aim o he s udy was o explo e he impo ance o MT se um le els
in child en su e ing om malignan umou s. This p ospec i e s udy in ol es examina ion
o 865 samples om 172 pa ien s wi h malignan umou s ea ed om 2008 o 2011 a
Uni e si y Hospi al Mo ol. MT se um le els we e de e mined using di e en ial pulse
ol amme y–B dicka eac ion. Mean MT le el was 2.7 ± 0.5 μM. The e was no
s a is ically signi ican di e ence be ween MT le els in di e en umou s. We also did no
ind any co ela ion be ween MT le els and esponse o he apy o clinical s ages.
Howe e , we ound a posi i e co ela ion be ween MT le els and age (p = 0.009) and a
nega i e co ela ion wi h absolu e lymphocy e numbe (p = 0.001). The ac ha pa ien s
who had ea ly disease ecu ence had lowe MT le els du ing he ea men (comple e
OPEN ACCESS
In . J. Mol. Sci. 2013, 14 12171
emission 2.67 s. ecu ing 2.34, p = 0.001) seems o be impo an o clinical p ac ice.
Acco dingly we belie e ha he e is bene i in u he s udies o se um MT le els
in umou s.
Keywo ds: se um me allo hioneins; child en; solid umou s; ea men ; di e en ial pulse
ol amme y B dicka eac ion
1. In oduc ion
Me allo hioneins (MTs) a e low molecula weigh cys eine ich p o eins, which ha e na u ally
occu ing Zn2+ in bo h binding si es [1]. They a e ound in he cy oplasm and a ious subcellula
o ganelles, pa icula ly in li e , kidney and in es inal cells [2,3]. Fou majo me allo hionein iso o ms
ha e been iden i ied in mammals (MT 1–4). MT-1 and 2 a e ubiqui ous, and hei main unc ions a e
he egula ion o coppe and zinc me abolism and he de oxi ica ion o hea y me als. They pe o m
se e al unc ions o gas oin es inal ac , a e in ol ed in cell ansc ip ion, and play a ole in immune
unc ion. MT-3 (also called neu onal g ow h-inhibi o y ac o ) is ound in he b ain and small le els
a e p esen in he panc eas and in es ines. MT-3 is syn hesized p ima ily in he as ocy es o co ex,
b ains em and spinal co d [4]. I s main unc ion is a g ow h inhibi o y ac o in b ain [5]. MT-4 is
loca ed in he epi helial cells o skin, ongue and s omach. I pa icipa es in he egula ion o s omach
acid pH, as e and ex u e disc imina ion o he ongue, and helps o p o ec he skin agains damage
om UV ligh [6,7]. Expe imen al s udy has shown educed neu onal p o ec ion agains oxida i e
s ess-induced damages in MT knockou mice [8]. Howe e , mice wi h dele ions o bo h he MT-1 and
MT-2 genes do no exhibi an al e ed pheno ype unde no mal condi ions [9–12]. MT-1 and MT-2,
unlike MT-3 and MT-4, a e highly inducible in mammalian cells by di e en s imuli (hea y me als,
cy okines). A signi ican associa ion be ween me al le els, MT exp ession, and disease was ound in
a ious issues [6,7].
The e a e some expe imen al and clinical p eceden s o sugges ing ha MTs can be expo ed and
aken up by cells h ough a ecep o -media ed mechanism [13]. High le els o MTs we e de ec ed in
sec e ed panc ea ic juice a e piloca pine s imula ion in mice [10]. Bilia y exc e ion o MT-1 ose in
a s ed wi h a high coppe die [12]. MTs we e eleased a e he induc ion o di e en ia ion o
ib oblas ic p eadipocy es in o adipocy es in i o) [11]. MTs we e de ec ed in human seminal plasma
sec e ed p edominan ly om he p os a e [14].
MTs could be e y impo an o pa ien s who a e unde going an i-cance he apy. They ha e
an iapop o ic, an ioxidan , p oli e a i e and p oangiogenic e ec s ha a e impo an in oncogenesis,
umou p og ession and esponse o an icance he apy [1,3,15–18]. MTs a e also in ol ed in
esis ance o cy os a ic d ugs, because hey educe d ug up ake, inc ease d ug e lux and pa icipa e in
DNA epai [17–22]. The e is a g ea deal o in o ma ion abou cellula MT con en in di e en
cance s and abou i s p ognos ic signi icance [1,23]. Howe e , he e is limi ed knowledge abou se um
le els in cance pa ien s and so a , he e a e no conclusi e da a on he signi icance o MT se um le el
in child pa ien s. MT-2A is he mos exp essed MT human iso o m because o he binding abili y o
In . J. Mol. Sci. 2013, 14 12172
enhance s in he MT-2A p omo e egion [24]. Howe e , he in o ma ion on se um le els o indi idual
iso o ms is s ill lacking.
The aim o his s udy is o explo e ela ionships be ween MT se um le els and ype o umou ,
s ages and esponse o he apy in child en su e ing om solid umou s. We also we e looking o
co ela ion be ween MT le els and o he labo a o y indings.
2. Resul s
2.1. MT in Se um
The mean MT le el in child en wi h malignan umou s was 2.67 ± 0.5 μM. The e we e no s a is ically
signi ican di e ences be ween di e en umou s in ou g oup o pa ien s (Figu e 1). The highes mean
MT le els we e ound in ge m cell umou s (MTs 2.94 ± 0.9 μM) and he second highes le els we e
de e mined in b ain umou s (2.82 ± 0.5 μM) bu he di e ences a e no s a is ically signi ican and a e
p obably caused by age dis ibu ion. We p e iously published a e age MT le els in se um o heal hy
adul olun ee s de ec ed also using he B dicka me hod. In he sample (mean age 27 yea s), MT le el
was 0.52 ± 0.2 μM [25]. Milne owicz and Bizoń ound simila esul s in heal hy adul olun ee s using
enzyme-linked immunoso ben assay [26] and Singh and Hanson ound lowe MT le els in 50 no mal
child en (aged 2–11 yea s) by immunoassay (app ox. 2 mg/L) [27]. Somewha highe we e MT le els
de ec ed by di e en ial pulse ol amme y–B dicka eac ion ound in a g oup o child en (age 3–17
yea s) wi h a ious enal diseases wi h no mal c ea inine le els (MTs 1.42 ± 0.09 μM) [28]. Those
le els in heal hy adul con ols a e app oxima ely i e imes lowe han he a e age (2.67 ± 0.5 μM)
MT le els ound in ou g oup o pa ien s. The MT le els in he g oup o child en wi h enal diseases
we e oughly hal ha o alues in child en su e ing om malignan umou s. Bo h hose di e ences
we e s a is ically signi ican (T- es , p < 0.01). The MT le els ound in a g oup o child en wi h
nonmalignan kidney diseases we e app oxima ely hal o le els in ou g oup wi h malignan umou s.
We ound highly signi ican posi i e co ela ion be ween MT le els and age ha was independen o
umou ype. Figu e 1 depic s a gene al linea model wi h dependen a iable MT le el, be ween
subjec s ac o ype o umou and co a ia e age, displaying signi icance o co a ia e e ec age
p = 0.009 (F = 7.05, d = 1), pa ame e es ima e o age B = 0.023 (posi i e).
2.2. MT Rela ionship o Cou se o he Disease
We did no ind any di e ences in MT le els among pa ien s wi h umou s be o e s a ing he apy,
wi h umou and/o me as ases du ing he apy o wi h p og essi e disease (g oup o “pa ien s wi h
ac i e disease”) and pa ien s in comple e emission (g oup wi hou “ac i e disease”). The e we e no
s a is ically signi ican di e ences in MT le els in pa ien s wi h me as a ic diseases in compa ison wi h
le els in pa ien s wi h localized cance . The majo i y pa ien s displaying lowe MTs le els had ea ly
ecu ence o disease. A e age MT le els du ing all ollow up pe iod be o e de ec ion o ecu ence
was 2.34 μM, e sus comple e emission 2.67 μM (p = 0.001). These esul s a e shown in Figu e 2.
We, howe e , ound signi ican dec ease o MT le els in child en du ing ollow up ≥2 mon hs a e he
end o he ea men as compa ed wi h le els a he end o he apy (p = 0.001, Figu e 3).
In . J. Mol. Sci. 2013, 14 12173
Figu e 1. MT le el/mean ± s.d./in di e en childhood malignan umou s. Ha ched column:
all umou s; do ed columns: heal hy adul olun ee s. The e we e no s a is ically signi ican
di e ences be ween di e en umou s, di e ence be ween MT le els in all malignan
umou s and in heal hy olun ee s was signi ican . MMT: So issue sa coma (Malignan
mesenchymal umou s).
Figu e 2. Rela ion o MT le el/mean ± s.d./ o clinical pa ame e s. N.S.: no signi ican .
p = 0.001: s a is ically signi ican on he le el o 0.1%. The e we e no s a is ically
signi ican di e ences be ween MT le els in pa ien s wi h ac i e disease and in emission
o in pa ien s wi h gene alized disease and wi h cance s wi hou me as asis.
Figu e 3. MT le els/mean ± s.d./in g oup o pa ien s <2 mon hs a e inishing
chemo he apy compa ed o pa ien s ≥2 mon hs a e inishing chemo he apy [pai ed T- es
( = 3.53, d = 75) p = 0.001].
In . J. Mol. Sci. 2013, 14 12174
2.3. MT Le els and Chemo he apy
MT le els in pa ien s wi h ac i e disease we e highe in hose ea ed wi h chemo he apy han
wi hou (p = 0.02). The e was no signi ican di e ence in MT le els in pa ien s ea ed by p o ocols
con aining pla inum cy os a ics and ea ed wi hou hose cy os a ics (Figu e 4).
Figu e 4. MT le els in ela ion o chemo he apy. N.S.: no signi ican . p = 0.02: s a is ically
signi ican on he le el o 2%. The only signi ican di e ence was ound be ween le els in
pa ien s wi h ac i e umou (be o e he apy, pa ial emission, p og essi e disease) wi h and
wi hou chemo he apy. The e was no ela ionship o chemo he apy wi h pla inum cy os a ics.
2.4. Co ela ion o MT Le els wi h O he Biochemical Pa ame e s
The e was a nega i e co ela ion be ween MT le els and absolu e lymphocy e coun (p = 0.001)
and posi i e co ela ion be ween MT and c ea inine le els (p = 0.003). Co ela ion be ween
haemoglobin and MT le els was below he le el o s a is ical signi icance (p = 0.085). Pa ien s wi h
CRP abo e no mal le els exhibi ed no di e ence in MT le el compa ed o hose wi h no mal CRP
(p = 0.912). Summa y o he esul s ob ained is shown in Table 1. Co ela ions o MT le els wi h
o he labo a o y indings men ioned in Ma e ials and me hods we e no signi ican .
Table 1. Co ela ions be ween labo a o y pa ame e s.
Co ela ions
MT ANL CRP Hgb
MT Pea son 1 −0.252 ** 0.009 0.132 #
Sig. (2- ailed) - 0.001 0.912 0.085
N 172 171 152 171
ANL Pea son −0.252 ** 1 −0.126 −0.040
Sig.(2- ailed) 0.001 - 0.119 0.599
N 171 174 154 174
CRP Pea son 0.009 −0.126 1 0.039
Sig. (2- ailed) 0.912 0.119 - 0.635
N 152 154 154 154

In . J. Mol. Sci. 2013, 14 12175
Table 1. Con .
Co ela ions
MT ANL CRP Hgb
Hgb Pea son 0.132 −0.040 0.039 1
Sig. (2- ailed) 0.085 0.599 0.635 -
N 171 174 154 174
C ea Pea son 0.273 −0.381 0.170 0.445
Sig. (2- ailed) 0.003 0.000002 0.036 0.000001
N 170 173 153 173
ANL: absolu e lymphocy e numbe ; CRP: C- eac i e p o ein, Hgb: haemoglobin, C ea: c ea inine. ** p < 0.01,
# nea he le el o s a is ical signi icance.
3. Discussion
Nume ous s udies ha e been ca ied ou o unde s and he ela ionship be ween MT in cells and
cance . Mos o hese ha e ocused on adul s [6,18,29–33] and a ewe on child en [34–37]. S udies
in adul s ha e shown ha cellula MT could se e as p ognos ic ma ke s in some umou s [17,38–43].
Rela ionships ha e been desc ibed be ween MT and p53 s a us [1], inc eased umou g ade [44,45] and
me as ases de elopmen [1,46]. Howe e wha has been p o ed in adul s is no so clea in childhood
cance s. The e is one s udy in child en wi h os eosa coma, whe e he au ho s ound di e en ial
exp ession o MT in biopsies [36] and hey sugges ed ha MT migh play an impo an ole in
de elopmen o disease. Ano he s udy on child en su e ing om leukaemia showed ha pa ien s wi h
acu e lymphoblas ic leukaemia whose blas s exp ess MT ended o ha e sho e disease- ee su i al
compa ed wi h he MT nega i e ones [37]. A u he epo on pa ien s wi h neu oblas oma demons a ed
only limi ed alue o MT o p edic ion o he apeu ic esponse [34].
MT le els in se um ha e seldom been esea ched in cance pa ien s. They ha e been used o
moni o ing in oxica ion by me als (lead, cadmium) [47]. P e iously, ou g oup has published h ee
publica ions on MT in se um in adul cance . Inc eased MT se um le els in p os a e cance pa ien s
we e ound o be nega i ely co ela ed wi h hei Gleason sco e [48]. MT le els in pa ien s su e ing
om head and neck spinocellula cance demons a ed co ela ion wi h umou g ade and clinical
s age [49,50]. In ano he s udy hepa ocellula ca cinoma se um MT le els we e dec eased compa ed o
he con ol g oup [51]. To ou knowledge no wo k has ye been published on MT se um le els in child
cance pa ien s.
Ou s udy co e ed a wide ange o child cance s. MTs we e ound no o ac as a p ognos ic ma ke
o ea men esponse in any o hese diseases. Pa ien s wi h me as ases o p og essi e disease did no
exhibi di e en MT le els ei he . Di e ences be ween di e en ypes o umou s we e no signi ican .
The highes mean MT le els we ound we e in ge m cell umou s (MT 2.94 ± 0.9 μmol·dm−3) mos
likely because hese included a highe p opo ion o olde pa ien s. The second highes we e in b ain
umou s (2.82 ± 0.5 μmol·dm−3)—p obably because he b ain, in gene al, con ains highe amoun s o
MT [16,52,53], bu age dis ibu ion may also play a ole. Du ing an icance he apy he e a e many
di e en pa hological eac ions ( issue damage induced by cy os a ics and/o adio he apy, suppo i e
he apy including an ibio ics and an imyco ics, e y h opoe in and/o ilg as im, in ec ions, umou
beha iou , e c.). Each o hese con ibu es o a ious and hence con inuously a ying le els o
In . J. Mol. Sci. 2013, 14 12176
oxida i e s ess. MTs a e known o unc ion as one o he main an ioxidan de ence sys ems [1,54,55].
Changes o MT le els caused by he apy and/o i s complica ions men ioned abo e a e p obably he
main eason why co ela ion be ween umou ac i i y and MT le els is no signi ican . We ha e no
ound signi ican co ela ion be ween umou ac i i y and MT le els.
The inding ha low MT le els du ing ea men we e closely co ela ed wi h ea ly elapses may be
impo an o clinical p ac ice. Peye e e al. ound ha up o 80% o child en wi h ecu ence o
ependymoma ha e down- egula ed MT-3 genes, no caused by MT gene dele ion o p omo e
me hyla ion. MT-3 exp ession was es o ed by his ondeace ylase inhibi o o zinc ea men [35]. One
may sugges ha down- egula ion could be a key cause o low MT le els in pa ien s su e ing om
ecu ence, al hough om wel e ecu en umou s, only h ee we e b ain umou s and i is no known
i o he MT iso o ms exp ession is also down egula ed in ecu en umou s o o he o gans.
The explana ion o slow decline (2 mon hs) o MT le els a e comple ing he apy is long eco e y
eac ions in he o ganisms a e he end o ea men . We choose a wo mon h limi because i is an
in e al in which haema opoiesis and immuni y is usually econs i u ed a e con en ional doses o
chemo he apy, and one may specula e ha o he sys ems a e also no malized du ing his in e al [56].
This sugges s ha chemo he apy in luences MT le els by mul iple mechanisms e.g. he damage o
di e en o gans and sys ems, he inc easing isk o in ec ions, and/o by he p oduc ion o eac i e
oxygen species. I will be necessa y o obse e hese pa ien s o e longe pe iods o de e mine when
MT le els e u n o no mal. We sugges ha changes o MT le els could be conside ed as a p omising
ma ke o la e elapses. In ou s udy we did no ha e pa ien s who su e la e ecu ence mo e han 2
yea s a e he end o ea men . The ac ha MT le els declined du ing he wo mon hs ollowing he
end o ea men suppo s ou iew ha he an icance and suppo i e he apy signi ican ly a ec s he
se um le els o MT.
MT plays an impo an ole in chemo esis ance and no only o me al con aining d ugs. Thei
exp ession may be inc eased no only by me als bu by o he s imuli e.g. glucoco icoids, ca echolamines,
ee adicals, umou nec osis ac o α, in e leukins-1, -2 and -6 [1,17]. P oduc ion o some hose
MT-inducing biologically ac i e molecules is s imula ed by chemo he apy. This may explain inc eased
MT le els in pa ien s wi h “ac i e umou s” ea ed wi h chemo he apy.
The indings o inc eased MT le els in pa ien s wi h ac i e disease (wi h umou s be o e s a ing
he apy, wi h umou and/o me as ases du ing he apy o wi h p og essi e disease) bu no in emission
ea ed by cy os a ics may be explained by he p oduc ion o MT by cance cells s imula ed by
chemo he apy. MTs a e able o bind pla inum-based cy os a ics and he eby educe hei cy o oxic
e ec . Chemo esis ance o pla inum an i- umou compounds is media ed h ough se e al mechanisms.
One o hem is he ans e o pla inum om cispla in and ca bopla in o MT ha esul s in inac i a ion
o hose d ugs. Cul i a ion o neu oblas oma cells esis an o cispla in in medium wi h cispla in o
ca bopla in, has been shown o signi ican ly inc ease in acellula MT le els [1]. Howe e in a
sensi i e cell line only insigni ican inc eases in MT we e de ec ed a e cul i a ion wi h he same
concen a ions o cispla in o ca bopla in [1]. Ano he s udy showed ha a cispla in- esis an o a ian
cance cell line exposed o cispla in mani es ed a nuclea MT exp ession [57]. In hepa oblas oma
pa ien s ea ed wi h ca bopla in, i was e i ied ha non- esponde s had a highe pe cen age o
MT-posi i e umou cells [58]. The signi icance o MT exp ession o esis ance o gas ic cance o
cispla in was e i ied by Suganuma e al. [59]. MT up egula ion was de ec ed in medulloblas oma and
In . J. Mol. Sci. 2013, 14 12177
habdomyosa coma cells wi h induced esis ance o he alkyla ing d ug BCNU [60]. Esophageal
ca cinomas which do no exp ess MT, espond well o chemo adio he apy (5- luo ou acil and
cispla in) while cance s wi h high MT exp ession a e esis an [61]. Women wi h b eas ca cinoma
ea ed wi h chemo he apy (cyclophosphamide, me ho exa e, 5 luo ou acil o doxo ubicin) had
signi ican ly longe su i al i hei umou s had lowe MT exp ession [42]. Hishikawa and co-wo ke s
ound ha MT nega i e pa ien s wi h oesophageal cance ea ed wi h cispla in expe ienced inc eased
su i al compa ed o hose wi h MT posi i e umou s [62].
I has been ound ha MT exp ession ini ially inc eases wi h age, bu hen dec eases in people o e
se en y [63] and he inducibili y o MT inc ease wi h age in in an a model was desc ibed by
Baue ly [64]. Co ela ion o se um MT le els ound in ou s udy may also indi ec ly con i m his
phenomenon. Na ale e al. showed in animal expe imen s ha low MT explains enhanced suscep ibili y o
neu onal loss a e inju y in imma u e b ains [53]. I is common knowledge ha chemo he apy is mo e
oxic in e y young child en compa ed o olde child en. Ou indings o low MT in in an pa ien s
could be one o he possible easons o mo e se ious side e ec s o chemo he apy and adio he apy in
in an s compa ed o olde child en.
The possible explana ion o dec eased MT in pa ien s wi h highe c ea inine le els may be kidney
damage, as hey a e one o he majo p oduce s o MTs. MT-1 and MT-2 a e p oduced pa icula ly in
kidney, li e , panc eas and in es ine [1]. The posi i e co ela ion o MT le els and lymphocy e coun
in cance pa ien s do no ha e a clea explana ion. Due o signi ican co ela ions be ween se um
c ea inine and lymphocy e coun s and haemoglobin le els, i is di icul o assess whe he he
ela ionship be ween MT and c ea inine is p ima y, o whe he he e a e p ima y ela ionships o
haema ological pa ame e s. I is possible ha he induc ion o MT by cy okines such as in e leukin-1,
-2 and -6 o umou nec osis ac o , which a e p oduced by lymphocy es, may play a possible ole.
I has been ound ha zinc supplemen a ion in luences lymphocy e p oduc ion [63,65]. The au ho s
looked a changes in la ge numbe s o genes ha we e in ol ed in zinc homeos asis in pe iphe al
blood leukocy es o child en wi h sep ic shock. MT exp ession in child en who died was also
inc eased. I was sugges ed ha decline in zinc concen a ions among c i ically ill child en was ela ed
o shi s in MT exp ession and low plasma zinc le els we e associa ed wi h he deg ee o o gan
ailu e [64–66]. Child pa ien s who ha e low lymphocy e coun also ha e inc eased isk o sepsis. In
ou s udy we no iced ha pa ien s wi h low lymphocy e coun had inc eased MT le els. Th ee o ou
pa ien s had li e h ea ening sepsis du ing leucopoenia and high se um MT le els—2.1 imes highe
han mean (da a no shown), which is in ag eemen wi h he s udies men ioned abo e. The ac ha
CRP did no co ela e wi h MT le els sugges s ha MTs a e no acu e-phase p o eins, and may be a
labo a o y ma ke ha is independen o acu e-phase.
4. Expe imen al Sec ion
4.1. Pa ien s
This p ospec i e s udy in ol es examina ion o 865 samples om 172 pa ien s wi h malignan
umou s ea ed a he Depa men o Paedia ic Haema ology and Oncology, Uni e si y Hospi al
Mo ol om 2008 o 2011. Samples we e collec ed be o e s a ing chemo he apy, du ing chemo he apy
In . J. Mol. Sci. 2013, 14 12178
and a e . Diagnoses and age dis ibu ion see Table 2. The g oup included 71 gi ls (41%) and 101 boys
(59%). O he clinical pa ame e s we e: me as a ic disease 93 (54.1%), dea h du ing ollow up 32 (18.6%),
ecu ence du ing ollow up 12 (7%). The minimal ollow up was 18 mon hs and median ollow up
was 39 m (Table 2).
Table 2. Clinical cha ac e is ics o pa ien s g oup.
Diagnosis No. o
pa .
Median
age
Minimum
age
Maximum
age Recu ence Me as a ic Chemo he apy/
P cy os aic **
Neu oblas oma 33 1 y 8 m 1 m 15 y 3 24 30/24
B ain umou s 27 9 y 2 m 8 m 15 y 4 m 3 3 * 27/16
Lymphoma 24 15 y 10 m 9 m 18 y 4 m 2 / 24/0
Ewing sa coma 20 12 y 7 m 1 y 5 m 18 y 3 m 0 3 20/0
Ge m cell umou s 14 16 y 4 m 6 m 19 y 6 m 1 10 14/14
Os eosa coma 12 13 y 1 m 6 y 5 m 16 y 11 m 1 3 12/12
So issue sa coma 12 10 y 8 m 1 y 8 m 16 y 6 m 1 1 12/0
Neph oblas oma 7 1 y 9 m 9 m 6 y 10 m 1 3 7/2
O he malignan
umou s 23 16 y 4 m 6 m 19 y 6 m 0 9 16/2
All 172 9 y 11 m 1 m 19 y 6 m 12 56 162/70
* spinal me as ases, ** no o ea ed by any cy os a ic/no o ea ed by P con aining cy os a ic (cispla in and/o ca bopla in).
In ou s udy we in es iga ed he co ela ion be ween MT le els and clinical pa ame e s (age,
diagnosis, clinical s age, ecu ence and esponse o an icance he apy). We also compa ed MT le els
examined be o e, du ing and a e he apy wi h o he labo a o y indings: o al blood coun and u ea,
c ea inine, u ic acid, lac a e dehyd ogenase, ansaminases, bili ubin, e i in, o al p o ein, and C- eac i e
p o ein (CRP) de e mina ion. To al blood coun was examined a he Depa men o Clinical
Haema ology, and o he biochemical es s a Depa men o Clinical Biochemis y and Pa hobiochemis y,
Uni e si y Hospi al Mo ol, acco ding o s anda d p o ocols.
4.2. De e mina ion o Me allo hioneins
Samples we e p epa ed by hea ea men using an au oma ed pipe ing sys em epMo ion 5075
(Eppendo , Hambu g, Ge many) and kep a 4 °C hen ans e ed o he 96 well pla es (Eppendo ,
Hambu g, Ge many) oge he wi h 0.2 M phospha e bu e pH 7. This mix u e was kep a 99 °C o
15 min. The las s ep was cooling down o samples o 4 °C. Hea ing dena u es and emo es he high
molecula weigh p o eins om samples [67]. MT quan i ica ion was de e mined by elec ochemical
de ec ion. Di e en ial pulse ol amme ic B dicka eac ion measu emen s we e pe o med using a
747 VA S and ins umen connec ed o a 693 VA P ocesso and 695 Au osample (Me ohm, He isau,
Swi ze land), using a s anda d cell wi h h ee elec odes, a cooled sample holde and measu emen
cell. Measu emen s we e aken on samples cooled o 4 °C (Julabo F25, Julabo, Seelbach, Ge many). A
hanging me cu y d op elec ode (HMDE) wi h a d op a ea o 0.4 mm2 was he wo king elec ode. An
Ag/AgCl/3M KCl elec ode was he e e ence and pla inum elec ode was auxilia y. Fo da a
p ocessing VA Da abase 2.2 by Me ohm was employed. The analysed samples we e deoxygena ed
p io o measu emen s by pu ging wi h a gon (99.999%) sa u a ed wi h wa e o 120 s. A B dicka
In . J. Mol. Sci. 2013, 14 12185
74. K izko a, S.; Adam, V.; Eckschlage , T.; Kizek, R. Using o chicken an ibodies o
me allo hionein de ec ion in human blood se um and cadmium- ea ed umou cell lines a e
do - and elec oblo ing. Elec opho esis 2009, 30, 3726–3735.
75. K iziko a, S.F. I; Adam, V.; Kukacka, J.; P usa, R.; Cha is, G.J.; T nko a, L.; S nadel, J.;
Ho ak, V.; Kizek, R. U ilizing o adso p i e ans e s ipping ecchnique b dicka eac ion o
de e mina ion o me allo hioneins le el in melanoma cells, blood se um and issues. Senso 2008,
8, 3106–3122.
© 2013 by he au ho s; licensee MDPI, Basel, Swi ze land. This a icle is an open access a icle
dis ibu ed unde he e ms and condi ions o he C ea i e Commons A ibu ion license
(h p://c ea i ecommons.o g/licenses/by/3.0/).